These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 15824886)
1. Observations on recovery from and recurrence of HSV-2 infections in adult mice that were rescued from lethal vaginal infection by antiviral therapy. Parr EL; Holliday EM; Collard MW; Parr MB Arch Virol; 2005 Sep; 150(9):1885-902. PubMed ID: 15824886 [TBL] [Abstract][Full Text] [Related]
2. The effect of daily valacyclovir suppression on herpes simplex virus type 2 viral shedding in HSV-2 seropositive subjects without a history of genital herpes. Sperling RS; Fife KH; Warren TJ; Dix LP; Brennan CA Sex Transm Dis; 2008 Mar; 35(3):286-90. PubMed ID: 18157071 [TBL] [Abstract][Full Text] [Related]
3. An international, randomized, double-blind, placebo-controlled, study of valacyclovir for the suppression of herpes simplex virus type 2 genital herpes in newly diagnosed patients. Fife KH; Warren TJ; Justus SE; Heitman CK; Sex Transm Dis; 2008 Jul; 35(7):668-73. PubMed ID: 18461016 [TBL] [Abstract][Full Text] [Related]
4. Valacyclovir and acyclovir for suppression of shedding of herpes simplex virus in the genital tract. Gupta R; Wald A; Krantz E; Selke S; Warren T; Vargas-Cortes M; Miller G; Corey L J Infect Dis; 2004 Oct; 190(8):1374-81. PubMed ID: 15378428 [TBL] [Abstract][Full Text] [Related]
5. One-day regimen of valacyclovir for treatment of recurrent genital herpes simplex virus 2 infection. Bavaro JB; Drolette L; Koelle DM; Almekinder J; Warren T; Tyring S; Wald A Sex Transm Dis; 2008 Apr; 35(4):383-6. PubMed ID: 18362859 [TBL] [Abstract][Full Text] [Related]
6. A mouse model for studies of mucosal immunity to vaginal infection by herpes simplex virus type 2. Parr MB; Kepple L; McDermott MR; Drew MD; Bozzola JJ; Parr EL Lab Invest; 1994 Mar; 70(3):369-80. PubMed ID: 8145530 [TBL] [Abstract][Full Text] [Related]
7. Suppressive therapy with valacyclovir in early genital herpes: a pilot study of clinical efficacy and herpes-related quality of life. Handsfield HH; Warren T; Werner M; Phillips JA Sex Transm Dis; 2007 Jun; 34(6):339-43. PubMed ID: 17065847 [TBL] [Abstract][Full Text] [Related]
9. Reducing the risk of transmitting genital herpes: advances in understanding and therapy. Leone P Curr Med Res Opin; 2005 Oct; 21(10):1577-82. PubMed ID: 16238897 [TBL] [Abstract][Full Text] [Related]
10. Valacyclovir prophylaxis to prevent recurrent herpes at delivery: a randomized clinical trial. Sheffield JS; Hill JB; Hollier LM; Laibl VR; Roberts SW; Sanchez PJ; Wendel GD Obstet Gynecol; 2006 Jul; 108(1):141-7. PubMed ID: 16816068 [TBL] [Abstract][Full Text] [Related]
11. Valacyclovir for the suppression of recurrent genital herpes in human immunodeficiency virus-infected subjects. DeJesus E; Wald A; Warren T; Schacker TW; Trottier S; Shahmanesh M; Hill JL; Brennan CA; J Infect Dis; 2003 Oct; 188(7):1009-16. PubMed ID: 14513421 [TBL] [Abstract][Full Text] [Related]
13. Does frequency of genital herpes recurrences predict risk of transmission? Further analysis of the valacyclovir transmission study. Kim HN; Wald A; Harris J; Almekinder J; Heitman C; Corey L Sex Transm Dis; 2008 Feb; 35(2):124-8. PubMed ID: 17921912 [TBL] [Abstract][Full Text] [Related]
14. Valacyclovir for herpes simplex virus infection: long-term safety and sustained efficacy after 20 years' experience with acyclovir. Tyring SK; Baker D; Snowden W J Infect Dis; 2002 Oct; 186 Suppl 1():S40-6. PubMed ID: 12353186 [TBL] [Abstract][Full Text] [Related]
16. 3-Hydroxyphthaloyl beta-lactoglobulin. IV Antiviral activity in the mouse model of genital herpesvirus infection. Kokuba H; Aurelian L; Neurath AR Antivir Chem Chemother; 1998 Jul; 9(4):353-7. PubMed ID: 9875414 [TBL] [Abstract][Full Text] [Related]
17. Valacyclovir therapy to reduce recurrent genital herpes in pregnant women. Andrews WW; Kimberlin DF; Whitley R; Cliver S; Ramsey PS; Deeter R Am J Obstet Gynecol; 2006 Mar; 194(3):774-81. PubMed ID: 16522412 [TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of valacyclovir for the suppression and episodic treatment of herpes simplex virus in patients with HIV. Warren T; Harris J; Brennan CA Clin Infect Dis; 2004 Nov; 39 Suppl 5():S258-66. PubMed ID: 15494897 [TBL] [Abstract][Full Text] [Related]
19. Assessment trials of the therapeutic efficacy of the drug "Zovirax" in some recurrent ocular and genital herpetic infections. Muţiu A; Sahnazarov N; Crişan I Rom J Virol; 1998; 49(1-4):27-42. PubMed ID: 10892424 [TBL] [Abstract][Full Text] [Related]
20. Recurrent herpes simplex virus type 2 meningitis: a case report of Mollaret's meningitis. Kojima Y; Hashiguchi H; Hashimoto T; Tsuji S; Shoji H; Kazuyama Y Jpn J Infect Dis; 2002 Jun; 55(3):85-8. PubMed ID: 12195049 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]